Want to join the conversation?
Chicago-based pharmaceutical company $ABBV reported 4Q15 profit of $1.51Bil, or $0.92 per share compared to net loss of $810MM or $0.51 per share, a year earlier. Total revenue for the quarter grew 17% to $6.4Bil. Total company revenue growth was driven by $554MM in global VIEKIRA sales and strong operational growth from Duodopa, Creon and Lupron.
$BA won a $22 billion deal from SpiceJet, their largest order from an Indian airline.
$FB stock remained in the green territory after Raymond James upgraded shares to strong buy from outperform, on expectations that overall 4Q16 ad spending was strong.
$ARRY Good day for the stock, jumped 7%. Great gains !
2017 was supposed to be another record year for automotive industry. Still, $F Ford thinks its profit will dip in 2017..!!
$KKR to buy Hitachi’s power tool unit Hitachi Koki for $1.3 billion. Looks like KKR & Co is going strong in Japan! Remember when it bought Calsonic Kansei a while back?